Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-03

HELP vs SGMT: stock comparison and AI forecast

Helus Pharma Inc. (HELP) and Sagimet Biosciences Inc. (SGMT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

HELP Helus Pharma Inc.

Market Cap
$643M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

SGMT Sagimet Biosciences Inc.

Market Cap
$687M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

HELP · SGMT

Key facts

  • HELP and SGMT have similar market capitalizations ($643M and $687M).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricHELPSGMT
Market Cap$643M$687M
EPS–$-1.52

Financial Health

MetricHELPSGMT
Current Ratio–45.02x
Working Capital–$239M

Cash Flow

MetricHELPSGMT
Operating Cash Flow–-$42M

Income Statement

MetricHELPSGMT
Operating Income–-$53M
R&D Expense–$35M

Dividend & Shareholder Information

MetricHELPSGMT
Shares Outstanding73M71M
FAQ

HELP vs SGMT: stock comparison and AI forecast

Which is bigger, HELP or SGMT?

HELP and SGMT have similar market capitalizations ($643M and $687M).

Which one does Intratio's AI model rank higher, HELP or SGMT?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.